Personal health budget pilots to be assessed

October 12, 2009
Sales and Marketing NHS, hc

The success or otherwise of personal health budgets is to be assessed in a study on their benefits across 20 …

GSK patient page

Digital Pharma: GSK pushes patient information boundaries

October 12, 2009
Medical Communications GSK, digi, digital pharma, patient information

GlaxoSmithKline has launched a product information website for patients in the UK, becoming the second major pharma company to push …

Montreal gets manufacturing boost from Schering-Plough

October 9, 2009
Manufacturing and Production Canada, Merck

 Schering-Plough says it is planning to invest more than C$30 million ($28 million) to expand a pharmaceutical manufacturing facility in …

Head-to-head trial favours Shire’s Fosrenol

October 8, 2009
Research and Development, Sales and Marketing fosrenol, renal

Shire's Fosrenol could have a clinical advantage over rival drug Renagel from Genzyme, according to the results of what is …

Simponi approved in Europe

October 8, 2009
Sales and Marketing RA, Simponi, TNF

 Rheumatic disease drug Simponi has received marketing approval for Europe, where it will be marketed by Schering-Plough.The drug is indicated …

Paying their own way: pharma and doctors to share CME costs

October 8, 2009
Medical Communications CME

The UK could be heading for a major overhaul of its Continued Medical Education (CME), as pharma and doctors look …

Reshuffle at Rexam creates healthcare unit

October 7, 2009
Manufacturing and Production Rexam, packaging

Packaging giant Rexam is merging three of its units into one global healthcare division headed by former Rexam Pharma chief …

GSK agrees more government orders for H1N1 vaccine

October 7, 2009
Sales and Marketing GSK, h1n1, vaccines

GSK has agreed another 22 government orders for its adjuvanted swine-flu vaccine – an extra 149 million doses on top …

European pharma companies raided

October 7, 2009
Sales and Marketing EU, reg

Several pharma companies have been raided as part of ongoing European Commission investigations into competitiveness issues. Sanofi-Aventis, Novartis and generic …

GSK: Committed to improving UK clinical research

October 6, 2009
Research and Development GSK, GlaxoSmithKline, NHS

GSK is the second biggest pharma company in the world, and Britain’s biggest homegrown firm in the sector. That means …

Contract research news in brief

October 6, 2009
Research and Development CRO

Pharmafocus' periodic round-up of developments in the contract research sector includes contracts awarded to Inclinix, Foranep and Phase Forward and …

China to slash medicines prices in October

October 6, 2009
Sales and Marketing China, hc, price cuts, prices

The Chinese government has announced it will cut the prices of more than 2,300 drugs by an average of 12% …

Merck wins family business award for excellence

October 5, 2009
Sales and Marketing Merck

The oldest global pharma company Merck has received a Family Business Excellence Award, after impressing judges with the 12 generations …

AZ signs biomarker research deal

October 5, 2009
Research and Development AZ, Cancer

A deal between AstraZeneca and Cancer Research UK is set to expand biomarker research into how new drugs behave in …

Cervarix not to blame for UK post-vaccination death

October 5, 2009
Sales and Marketing Cervarix, NHS, reg, vaccines

The death of a 14-year-old girl who died shortly after having received a cervical cancer vaccine was caused by an …

Baxter’s H1N1 vaccine set for European licence

October 5, 2009
Sales and Marketing baxter, h1n1

Baxter’s swine-flu vaccine is third in line for approval in Europe, behind already approved rivals from GSK and Novartis.Regulatory advisors …

Sanofi says its H1N1 jab effective after one dose

October 2, 2009
Sales and Marketing Sanofi, h1n1

 Sanofi Pasteur, the vaccines division of the Sanofi-Aventis Group, has said its swine flu vaccine is effective after a single …

The Gateway to Local Adoption Series

Latest content